Home›Stock Screener›Piramal Pharma›Quarterly Results

Piramal Pharma Quarterly Results

Latest Quarter Net Profit
₹5 Cr
QSept 2026
Quarterly Results

Piramal Pharma quarterly results. In Sept 2026, Piramal Pharma (PPLPHARMA) reported revenue ₹2,671 Cr and net profit ₹5 Cr — revenue +25.8% YoY. View PPLPHARMA 52-week performance for the annual high/low range and current price position.

PPLPHARMA Quarterly Results — Revenue, Profit & EPS Highlights

Piramal Pharma latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. For annual financials, live price and key ratios, visit PPLPHARMA share price screener.

  • Revenue of ₹2,671 Cr in Sept 2026 (-5.0% vs Mar 2026, +25.8% vs Sept 2025)
  • Net Profit of ₹5 Cr in Sept 2026 (+155.6% vs Mar 2026, +105.1% vs Sept 2025)
  • EBITDA of ₹402 Cr in Sept 2026 (+16.9% vs Mar 2026)
  • Operating Margin of 13.0% in Sept 2026 (+3.0pp vs Mar 2026)
  • Earnings Per Share of ₹0.04 in Sept 2026 (+157.1% vs Mar 2026)

Piramal Pharma Quarterly Results — Revenue, EBITDA, Net Profit & EPS

PPLPHARMA quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Sept 2026 Mar 2026 Jun 2026 Sept 2025 Mar 2025 QoQ YoY
Revenue (₹ Cr) 2,671 2,811 2,379 2,124 2,812 -5.0% 25.8%
Net Profit (₹ Cr) 5 -9 -69 -99 154 - -
EBITDA (₹ Cr) 402 344 304 239 619 - -
EPS (₹) 0.04 -0.07 -0.52 -0.75 1.16 - -
Operating Margin (%) 13.0% 10.0% 9.0% 8.0% 20.0% - -

PPLPHARMA Share Price Trend — 1-Year Movement Across Quarterly Results

Piramal Pharma 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Also explore Piramal Pharma stock price data download to track price trends across different timeframes.

Profitability Ratios

Profit Margin 0.2%
EBITDA Margin 15.1%
Operating Margin 13.0%
ROE (Annual) 0.2%

Balance Sheet Highlights

Total Assets ₹17,965 Cr
Total Equity ₹8,163 Cr
Current Assets ₹ Cr
Current Liabilities ₹5,044 Cr

Cash Flow Analysis

Operating Cash Flow ₹1,653 Cr
Investing Cash Flow ₹-820 Cr
Financing Cash Flow ₹-39 Cr
Net Cash Flow ₹794 Cr

Current Market Data

Current Price ₹239.65
Exchange NSE
Last Updated Nov 19, 2026

PPLPHARMA vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Piramal Pharma latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2026
₹451,074.97 Cr 1900.0 16,617 1,995 +10.6% - 12.0% 228.9
Divis Laboratories
Sept 2026
₹294,139.19 Cr 11178.0 3,770 1,127 +26.3% - 29.9% 263.1
Torrent Pharmaceuti…
Mar 2026
₹188,719.51 Cr 4611.0 4,111 364 +27.7% +42.2% 8.9% 400.6
Apollo Hospitals
Sept 2026
₹126,832.45 Cr 8738.0 7,673 660 +15.2% - 8.6% 199.4
Laurus Labs
Sept 2026
₹125,946.78 Cr 2306.0 2,219 436 +21.7% - 19.6% 282.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores